发明名称 METHOD FOR THERAPY FOR B-CELL MALIGNANCY USING ANTAGONIST ANTI-CD40 ANTIBODY
摘要 <P>PROBLEM TO BE SOLVED: To provide a method for therapy for B-cell malignancy. <P>SOLUTION: The method for therapy for B-cell malignancy is provided. The method comprises a process for administration of a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity when the antibody binds a CD40 antigen on a normal human B cell, exhibits antagonist activity when the antibody binds a CD40 antigen on a malignant human B cell, and can exhibit antagonist activity when the antibody binds a CD40 antigen on a normal human B cells. Antagonist activity of the anti-C antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of malignant human B cells. <P>COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008074870(A) 申请公布日期 2008.04.03
申请号 JP20070305086 申请日期 2007.11.26
申请人 CHIRON CORP 发明人 CHU KETING;MASUOKA LORIANNE
分类号 A61K39/395;C12N15/09;A61P1/04;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P43/00;C07K16/18;C07K16/28;C07K16/30;C12N15/13;C12P21/08 主分类号 A61K39/395
代理机构 代理人
主权项
地址
您可能感兴趣的专利